SODium BICarbonate for Metabolic Acidosis in the ICU
Status:
Not yet recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
This trial aims to assess if, among adults in the ICU with metabolic acidosis, an infusion of
sodium bicarbonate diluted in 5% dextrose, compared with an infusion of 5% dextrose, reduces
Major Adverse Kidney Events within 30 days of randomization.
Phase:
Phase 3
Details
Lead Sponsor:
Australian and New Zealand Intensive Care Research Centre